Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial

JOURNAL ARTICLE published October 2010 in The Lancet

Authors: Johann Sebastian de Bono | Stephane Oudard | Mustafa Ozguroglu | Steinbjørn Hansen | Jean-Pascal Machiels | Ivo Kocak | Gwenaëlle Gravis | Istvan Bodrogi | Mary J Mackenzie | Liji Shen | Martin Roessner | Sunil Gupta | A Oliver Sartor